Frommeyer, Gerrit <br/><br/>
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.  [electronic resource] 

 -  Journal of cardiovascular electrophysiology  03 2018 
 - 471-476 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1540-8167 
<br/><br/><label>Standard No.: </label>10.1111/jce.13412  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials--drug effects<br/>Animals<br/>Anti-Arrhythmia Agents--pharmacology<br/>Calcium Channel Blockers--pharmacology<br/>Dantrolene--pharmacology<br/>Disease Models, Animal<br/>Electrocardiography<br/>Erythromycin<br/>Heart Rate--drug effects<br/>Heart Ventricles--drug effects<br/>Isolated Heart Preparation<br/>Long QT Syndrome--chemically induced<br/>Rabbits<br/>Ryanodine Receptor Calcium Release Channel--drug effects<br/>Time Factors<br/>Torsades de Pointes--etiology<br/>Veratridine